Prospective randomised marker-based trial to assess the clinical utility and safety of biomarker-guided immunosuppression withdrawal in liver transplantation
Sanchez-Fueyo A, Ferguson J, O'Beirne J, Simpson K, Tachtatzis P, Masson S, Quaglia A, Stahl D, Alexander G, Volk HD, Peacock J, Reinke P
Record ID 32015000651
English
Original Title:
Prospective randomised marker-based trial to assess the clinical utility and safety of biomarker-guided immunosuppression withdrawal in liver transplantation (LiverTOL-Dx Trial)
Details
Project Status:
Completed
URL for project:
https://fundingawards.nihr.ac.uk/award/13/94/55
URL for protocol:
https://fundingawards.nihr.ac.uk/award/13/94/55
Year Published:
2021
URL for published report:
https://fundingawards.nihr.ac.uk/award/13/94/55
Requestor:
NIHR Health Technology Assessment programme
URL for additional information:
https://fundingawards.nihr.ac.uk/award/13/94/55
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
England, United Kingdom
MeSH Terms
- Immune Tolerance
- Biomarkers
- Allografts
- Transplantation Tolerance
- Immunosuppressive Agents
- Immunosuppression Therapy
- Liver Transplantation
Contact
Organisation Name:
NIHR Health Technology Assessment programme
Contact Address:
NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name:
journals.library@nihr.ac.uk
Contact Email:
journals.library@nihr.ac.uk
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.